Clinical Trials Logo

Clinical Trial Summary

A First-in-Human, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912 in Healthy Korean Subjects


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04076293
Study type Interventional
Source Hanmi Pharmaceutical Company Limited
Contact
Status Completed
Phase Phase 1
Start date October 29, 2019
Completion date November 10, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05563961 - A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers N/A
Completed NCT02566733 - Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass Phase 4
Completed NCT04032782 - A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects Phase 1
Recruiting NCT06024421 - Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers Phase 1
Completed NCT02641340 - Fentanyl Sublingual Spray in Opioid Naive Participants Phase 1
Completed NCT01575587 - A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men Phase 1
Completed NCT00359541 - Voriconazole Blood Levels and Toxicity N/A